邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

2000—2023年国际老年人共病研究文献计量学分析

张宁,  张晓辰,  何牧,  孙晓红,  康琳,  曲璇,  朱鸣雷

downloadPDF
文章导航 > 协和医学杂志  > 2023 > 优先出版
张宁, 张晓辰, 何牧, 孙晓红, 康琳, 曲璇, 朱鸣雷. 2000—2023年国际老年人共病研究文献计量学分析[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2023-0516
引用本文: 张宁, 张晓辰, 何牧, 孙晓红, 康琳, 曲璇, 朱鸣雷. 2000—2023年国际老年人共病研究文献计量学分析[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2023-0516
shu
ZHANG Ning, ZHANG Xiaochen, HE Mu, SUN Xiaohong, KANG Lin, QU Xuan, ZHU Minglei. A Bibliometric Analysis of the Global Research on Multimorbidity in Older Adults From 2000 to 2023[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2023-0516
Citation: ZHANG Ning, ZHANG Xiaochen, HE Mu, SUN Xiaohong, KANG Lin, QU Xuan, ZHU Minglei. A Bibliometric Analysis of the Global Research on Multimorbidity in Older Adults From 2000 to 2023[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2023-0516
shu

2000—2023年国际老年人共病研究文献计量学分析

doi: 10.12290/xhyxzz.2023-0516

  • 1 中国医学科学院北京协和医院老年医学科, 北京 100730;

  • 2 中国医学科学院 北京协和医学院, 北京 100730

基金项目: 

中央高水平医院临床科研专项（2022-PUMCH-B-132）

详细信息
    通讯作者:

    孙晓红,E-mail:sunxiaoh2010@126.com

  • 中图分类号: R592

A Bibliometric Analysis of the Global Research on Multimorbidity in Older Adults From 2000 to 2023

  • 1 Department of Geriatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China;

  • 2 Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China

Funds: 

National High Level Hospital Clinical Research Funding（2022-PUMCH-B-132）

    摘要
  • 摘要: 目的 分析2000—2023年老年人共病领域的国际研究趋势及前沿热点，以期为老年人共病研究提供借鉴。 方法 检索Web of Science数据库，将文献类型限制为“ Article”或“ Review”，纳入发表时间为2000年1月1日—2023年10月24日老年人共病相关英文文献。采用VOSviewer 1.6.18软件对文献中的内容进行提取，并绘制国家（地区）、机构的合作网络图及关键词共现关系时间线图。采用CiteSpace 6.1.R6软件对作者、研究机构、国家（地区）等信息进行共现和聚类分析。采用R语言的“bibliometrix”包分析文献的关键词演变趋势。 结果 共获得老年人共病相关文献2590篇（包括Article 2230篇、Review 360篇）。自2000年来全球发文量快速增长，美国在该领域的发文量（907篇，35.02%）及总被引频次（31343次）均最多。加拿大多伦多大学（67篇，2.59%）的发文量最大，加拿大麦克马斯特大学的Jenny Ploeg（32篇，1.24%）是成果产出最多的作者。BMC Geriatr（99篇，3.82%）是收录老年人共病相关文献最多的期刊。该领域高频关键词主要为multimorbidity、olderadults、frailty、aging和polypharmacy。 结论 近年来，老年人共病的研究热点主要集中于老年人共病与衰老的关系，以及与共病相关的衰弱和多重用药方面。未来可更多围绕老年综合评估、初级卫生保健以及生活质量等内容进行研究。
    Abstract: Objective This study aims to analyze the research trends and cutting-edge hot spots in the field of multimorbidity in older adults from 2000 to 2023. Methods We conducted a search in the Web of Science Core Collection database, specifically looking for articles or reviews in English literature on multimorbidity in older adults published between January 1, 2000, and October 24, 2023. VOSviewer 1.6.18 software was used to extract the content in the literature and to draw the cooperative network diagram of countries(regions) and institutions and the timeline diagram of keyword co-occurrence relationship. CiteSpace 6.1.R6 software was used to co-occur and cluster analyse the information of authors, research institutions and countries(regions). The "bibliometrix" package in R was used to analyse the evolution of keywords in the literature. Results A total of 2590 documents were obtained, consisting of 2230 Articles and 360 Reviews. The worldwide publication count has significantly increased since 2000. Among the countries(regions), the United States has the highest number of publications (907 articles, accounting for 35.02% of the total) and total citations (31,343 times) in this field. In terms of institutions, the University of Toronto stands out with 67 articles (2.59%) as the top contributor. McMaster University's author, Jenny Ploeg is recognized as the most prolific authors, having published 32 articles (1.24%). When it comes to journals, BMC Geriatrics has the highest amount of literature related to multimorbidity (99 articles). The key areas of research in this field include multimorbidity, older adults, frailty, aging, and polypharmacy. Notably, there is growing interest in studying the relationship between multimorbidity and aging in older adults, as well as the impact of frailty and polypharmacy on multimorbidities. Conclusions In recent years, research on multimorbidities in the elderly has primarily centered around examining the correlation between comorbidities and aging, as well as exploring the impact of frailty and polypharmacy on individuals with multimorbidities. Future research could potentially delve into the significance of primary health care and comprehensive geriatric assessment in effectively managing comorbidities among older adults, while also emphasizing the importance of maintaining their overall quality of life.
    • HTML全文
    • 参考文献(34)
  • [1] . 闫伟, 路云, 张冉, 等. 基于 CHARLS 数据分析的我国老年人共病现状研究[J]. 中华疾病控制杂志, 2019, 23:426-430.
    [2] . Xu X, Mishra GD, Jones M. Evidence on multimorbidity from definition to intervention:An overview of systematic reviews[J]. Ageing Res Rev, 2017, 37:53-68.
    [3] . Kivimäki M, Strandberg T, Pentti J, et al. Body-mass index and risk of obesity-related complex multimorbidity:an observational multicohort study[J]. Lancet Diabetes Endocrinol, 2022, 10:253-263.
    [4] . Di Angelantonio E, Kaptoge S, et al. Association of Cardiometabolic Multimorbidity With Mortality[J]. JAMA, 2015, 314:52-60.
    [5] . Vetrano DL, Rizzuto D, Calderón-Larrañaga A, et al. Trajectories of functional decline in older adults with neuropsychiatric and cardiovascular multimorbidity:A Swedish cohort study[J]. PLoS Med, 2018, 15:e1002503.
    [6] . 王丽敏, 陈志华, 张梅, 等. 中国老年人群慢性病患病状况和疾病负担研究[J]. 中华流行病学杂志, 2019, 40:277-283.
    [7] . La DTV, Zhao Y, Arokiasamy P, et al. Multimorbidity and out-of-pocket expenditure for medicines in China and India[J]. BMJ Glob Health, 2022, 7:e007724.
    [8] . Muth C, Blom JW, Smith SM, et al. Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy:a systematic guideline review and expert consensus[J]. J Intern Med, 2019, 285:272-288.
    [9] . Liu W, Wu J, Zhang N, et al. Postural deformities in Parkinson's disease:A bibliometric analysis based on web of science[J]. Heliyon, 2023, 9:e14251.
    [10] . van Eck NJ, Waltman L. Software survey:VOSviewer, a computer program for bibliometric mapping[J]. Scientometrics, 2010, 84:523-538.
    [11] . Zhou J, Song D, Ma J, et al. Research trends in the mental health and multimorbidity of older people from 2002 to 2022:A bibliometric analysis via CiteSpace[J]. Front Psychiatry, 2023, 14:1117554.
    [12] . Wang L, Luo D, Hamdaoui O, et al. Bibliometric analysis and literature review of ultrasoundassisted degradation of organic pollutants[J]. Sci Total Environ, 2023, 876:162551.
    [13] . Ye B, Xie R, Mishra SR, et al. Bidirectional association between physical multimorbidity and subclinical depression in Chinese older adults:Findings from a prospective cohort study[J]. J Affect Disord, 2022, 296:169-174.
    [14] . Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health:results from the World Health Surveys[J]. Lancet, 2007, 370:851-858.
    [15] . Triolo F, Sjöberg L, Calderón-Larrañaga A, et al. Late-life depression and multimorbidity trajectories:the role of symptom complexity and severity[J]. Age Ageing, 2023, 52:1-9.
    [16] . Kroenke K, Strine TW, Spitzer RL, et al. The PHQ-8 as a measure of current depression in the general population[J]. J Affect Disord, 2009, 114:163-173.
    [17] . Alessandra Marengoni, Sara Angleman, Ren J. F. Melis, et al. Aging with multimorbidity:A systematic review of the literature[J]. Ageing Research Reviews, 2011, 10:430-439.
    [18] . Schiltz NK. Prevalence of multimorbidity combinations and their association with medical costs and poor health:A population-based study of U.S. adults[J]. Front Public Health, 2022, 10:953886.
    [19] . Li H, Chang E, Zheng W, et al. Multimorbidity and catastrophic health expenditure:Evidence from the China Health and Retirement Longitudinal Study[J]. Front Public Health, 2022, 10:1043189.
    [20] . Guo X, Zhao B, Chen T, et al. Multimorbidity in the elderly in China based on the China Health and Retirement Longitudinal Study[J]. PLoS One, 2021, 16:e0255908.
    [21] . Zheng DD, Loewenstein DA, Christ SL, et al. Multimorbidity patterns and their relationship to mortality in the US older adult population[J]. PLoS One, 2021, 16:e0245053.
    [22] . American Geriatrics Society Expert Panel on the Care of Older Adults With Multimorbidity. Guiding principles for the care of older adults with multimorbidity:an approach for clinicians[J]. J Am Geriatr Soc, 2012, 60:E1-E25.
    [23] . Boyd C, Smith CD, Masoudi FA, et al. Decision Making for Older Adults With Multiple Chronic Conditions:Executive Summary for the American Geriatrics Society Guiding Principles on the Care of Older Adults With Multimorbidity[J]. J Am Geriatr Soc, 2019, 67:665-673.
    [24] . Fraser HC, Kuan V, Johnen R, et al. Biological mechanisms of aging predict age-related disease co-occurrence in patients[J]. Aging Cell, 2022, 21:e13524.
    [25] . Salvioli S, Basile MS, Bencivenga L, et al. Biomarkers of aging in frailty and age-associated disorders:State of the art and future perspective[J]. Ageing Res Rev, 2023, 91:102044.
    [26] . Luo Y, Chen Y, Wang K, et al. Associations between multimorbidity and frailty transitions among older Americans[J]. J Cachexia Sarcopenia Muscle, 2023,14:1075-1082.
    [27] . Hanlon P, Nicholl BI, Jani BD, et al. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality:a prospective analysis of 493 737 UK Biobank participants[J]. Lancet Public Health, 2018, 3:e323-e332.
    [28] . Lipska KJ, Krumholz H, Soones T, et al. Polypharmacy in the Aging Patient:A Review of Glycemic Control in Older Adults With Type 2 Diabetes[J]. JAMA, 2016, 315:1034-1045.
    [29] . McCarthy C, Clyne B, Boland F, et al. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study):A cluster randomised controlled trial[J]. PLoS Med, 2022, 19:e1003862.
    [30] . Reeve E, Gnjidic D, Long J, et al. A systematic review of the emerging definition of 'deprescribing' with network analysis:implications for future research and clinical practice. Br J Clin Pharmacol[J]. 2015, 80:1254-1268.
    [31] . 陈旭娇, 严静, 王建业, 等. 老年综合评估技术应用中国专家共识[J]. 中华老年医学杂志, 2017, 36:471-477.
    [32] . Kernick D, Chew-Graham CA, O'Flynn N. Clinical assessment and management of multimorbidity:NICE guideline[J]. Br J Gen Pract. 2017, 67:235-236.
    [33] . Christopher Dowrick. Patient-centred care for multimorbidity:an end in itself?[J]. The Lancet. 2018, 392:4-5.
    [34] . Forman DE, Maurer MS, Boyd C, et al. Multimorbidity in Older Adults With Cardiovascular Disease[J]. J Am Coll Cardiol, 2018, 71:2149-2161.
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  110
  • HTML全文浏览量:  22
  • PDF下载量:  20
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-11-02
  • 录用日期:  2023-11-28
  • 网络出版日期:  2023-12-09

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！